                         SEQUENCE LISTING

<110>  CuRNA, Inc.
 
<120>  TREATMENT OF INSULIN GENE (INS) RELATED DISEASES BY INHIBITION OF
        NATURAL ANTISENSE TRANSCRIPT TO A INSULIN GENE (INS)

<130>  INS

<150>  US61/231,451
<151>  2009-08-05

<160>  11    

<170>  PatentIn version 3.5

<210>  1
<211>  469
<212>  DNA
<213>  Homo sapiens

<300>
<308>  NM_000207
<309>  2010-07-04
<313>  (1)..(469)

<400>  1
agccctccag gacaggctgc atcagaagag gccatcaagc agatcactgt ccttctgcca       60

tggccctgtg gatgcgcctc ctgcccctgc tggcgctgct ggccctctgg ggacctgacc      120

cagccgcagc ctttgtgaac caacacctgt gcggctcaca cctggtggaa gctctctacc      180

tagtgtgcgg ggaacgaggc ttcttctaca cacccaagac ccgccgggag gcagaggacc      240

tgcaggtggg gcaggtggag ctgggcgggg gccctggtgc aggcagcctg cagcccttgg      300

ccctggaggg gtccctgcag aagcgtggca ttgtggaaca atgctgtacc agcatctgct      360

ccctctacca gctggagaac tactgcaact agacgcagcc cgcaggcagc cccacacccg      420

ccgcctcctg caccgagaga gatggaataa agcccttgaa ccagcaaaa                  469


<210>  2
<211>  334
<212>  DNA
<213>  Homo sapiens

<400>  2
cagtagttct ccagctggta gagggagcag atgctggtac agcattgttc cacaatgcca       60

cgcttctgca gggacccctc cagggccaag ggctgcaggc tgcctgcacc agggcccccg      120

cccagctcca cctgccccac ctgcaggacc tctgcctttc tcgtttcttg ggagtgtaga      180

gaagcctcgt ccccgcacct aggtagagag cttccaccag gtgtgagccg cacaggtgtt      240

ggttcacaaa ggctgcggct gggtcaggtc cccagagggc cagcagcgcc agcaggggca      300

ggaggcgcat ccacagggcc atggcagaag gaca                                  334


<210>  3
<211>  582
<212>  DNA
<213>  Homo sapiens

<400>  3
gcacgagttt tttttttgct ggttcaaggg ctttattcca tctctctcgg tgcaggaggc       60

ggcgggtgtg ggctgcctgc gggctgcgtc tagttgcagt agttctccag ctggtagagg      120

gagcagatgc tggtacagca ttgttccaca atgccacgct tctgcaggga cccctccagg      180

gccaagggct gcaggctgcc tgcaccaggg cccccgccca gctccacctg ccccacctgc      240

aggtcctctg cctcccggcg ggtcttgggt gtgtagaagc tcgtgccgaa ttcggcacga      300

gcaaaggtgt tccacggaaa cacagacatg ttttctatcc caccttttct ttttaaaatg      360

aagtattttt gataaagtga attttaaaac acaaaatagc aatccccaaa gcacaagcta      420

acaatagtaa ttataatcat aattggcact tgtatataat gtcattttgc agggggttca      480

gccattttca caggcatcac ctagtctcag cagacacgtt tgagtttcct aggtcgtaaa      540

tctcattgtc tgtattctaa ggatataaaa tatgaaagtg aa                         582


<210>  4
<211>  20
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Antisense oligonucleotide

<400>  4
gcttcttcta cactcccaag                                                   20


<210>  5
<211>  19
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Antisense oligonucleotide

<400>  5
catctgctcc ctctaccag                                                    19


<210>  6
<211>  20
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Antisense oligonucleotide

<400>  6
ctctctacct agtgtgcggg                                                   20


<210>  7
<211>  20
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Antisense oligonucleotide

<400>  7
ctctctacct agtgtgcggg                                                   20


<210>  8
<211>  19
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Antisense oligonucleotide

<400>  8
catctgctcc ctctaccag                                                    19


<210>  9
<211>  20
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Antisense oligonucleotide

<400>  9
tctacacacc caagacccgc                                                   20


<210>  10
<211>  19
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Antisense oligonucleotide

<400>  10
tctgctccct ctaccagct                                                    19


<210>  11
<211>  21
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Antisense oligonucleotide

<400>  11
gcagaagcgt ggcattgtgg a                                                 21


